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Background: The purpose of this study was to evaluate the effectiveness of mandibular advancement devices
(MADs) for treatment of obstructive sleep apnea syndrome (OSAS) compared with the results obtained with a
placebo device in accordance with the following indicators: apnea hypopnea index (AHI) per hour of sleep, apnea
index (AI) per hour of sleep, mean oxyhemoglobin saturation, sleep efficiency, and percentage of rapid eye
movement (REM) sleep.
Methods: This is a controlled, prospective longitudinal study with a follow-up time of 10.5 months. Nineteen
patients (8 females and 11 males) with mean age 48.6 years (SD 9.6) were selected for the study. The sample was
randomized in terms of device use, and the evaluation design was double blind. A total of 57 polysomnography
tests were studied (at baseline, after the use of a MAD, and after the use of placebo). The following variables were
assessed: AHI, AI, mean oxyhemoglobin saturation, percentage of REM sleep, and sleep efficiency. Wilcoxon and
Mann–Whitney tests were used for evaluating data (p < 0.05).
Results: Reductions from 16.3 to 11.7 in AHI and from 5.7 to 3.8 in AI were observed after MAD use. During the use
of placebo, AHI increased from 16.3 to 19.6, and AI from 5.7 to 7.5. The other indexes showed no statistically
significant differences.
Conclusions: Treatment with oral appliances, i.e., MADs, can be an effective alternative for mild and medium-to-moderate
OSAS, but requires strict monitoring due to differences in individual response to this therapy.
Keywords: Obstructive sleep apnea syndrome (OSAS), Mandibular advancement oral appliance, Twin block,
Placebo, PolysomnographyBackground
Obstructive sleep apnea syndrome (OSAS) is character-
ized by recurrent events of upper airway obstruction dur-
ing sleep associated with clinical signs and symptoms [1].
Obstruction may involve awakening under the effect of in-
creased respiratory effort and a reduction (hypopnea) or
complete cessation (apnea) of airflow in the presence of
respiratory movements.
According to the American Association of Sleep Medi-
cine, OSAS diagnosis requires the occurrence of at least
five episodes of apnea hypopnea per hour of sleep com-
bined with clinical symptoms, the most important of which
are loud snoring and excessive daytime sleepiness [1]. The
apnea event is considered when the air flow is interrupted* Correspondence: andressaotranto@terra.com.br
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in any medium, provided the original work is pduring sleep for a period of 10 s or more, and hypopnea
when there is a reduction of at least 50% of the breathing
capacity combined with a saturation decrease of the
oxyhemoglobin in at least 3%.
This syndrome affects an average 4% of adult males
and 2% of adult females in the population, increasing as
of the fifth decade of life [2-7]. It is worrisome as it can
cause pulmonary hypertension and heart failure [1,8].
The ideal OSAS treatment, whatever it may be, should
be capable of normalizing breathing during sleep, conse-
quently eliminating excessive daytime sleepiness and
neuropsychiatric and cardiovascular changes [1]. At the
same time, it should provide patients with a good quality
of life with no side effects or risks [1,9].
OSAS treatment modalities range from sleep hy-
giene, which involves withdrawal from alcohol and
other drugs, proper body position, and slimming [1],an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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palatopharyngoplasty, and maxillomandibular advancement
procedures [1,2,8]. The most common clinical procedure
involves continuous positive airway pressure (CPAP)
[1,3,10,11]. Oral appliances have been recommended as a
treatment option for being simple to use and non-invasive
[12]. These devices are intended to increase the volume of
the airways through a mechanical maneuver [13-15].
Several authors stated in their studies [5,8,10,16,17] that
oral appliances are a good alternative for the treatment of
snoring and OSAS due to their low cost, relative comfort,
and ease of use, which can therefore lead to greater patient
compliance. Some issues, however, warrant further sub-
stantiation if the therapy is to become an effective and safe
alternative for treating these respiratory ailments [18-20].
Among these issues are a correct indication compatible
with OSAS severity [15,21], the diversity of available appli-
ances [12], definition of the basic features these appliances
should be able to provide [22], and differences in individ-
ual responses to therapy [23-25].
The purpose of this study was to evaluate the im-
provements obtained with a mandibular advancement
device compared with those obtained by a placebo de-
vice in accordance with the following indices: apnea
hypopnea index (AHI) per hour of sleep, apnea index
(AI) per hour of sleep, mean oxyhemoglobin saturation,
sleep efficiency, and percentage of REM sleep.
Methods
Subjects
Patients were selected by two neurologists certified in
sleep medicine. These physicians screened subjects in their
private offices based on medical history and evidence of
obstructive sleep apnea syndrome by means of overnight
polysomnography, in addition to a diagnosis indicating
that airflow obstruction was not located in the upper por-
tion of the upper airway (nose or nasopharynx). Based on
this diagnosis, whenever they believed a patient could be
treated with an oral appliance, he/she was referred for
evaluation to the orthodontic clinic of the postgraduateFigure 1 Twin block appliance in place. (A) Front view and (B) side viewprogram in Orthodontics at the School of Dentistry, State
University of Rio de Janeiro. Before sending to the School
of Dentistry, the patients were oriented about the different
treatment modalities for OSAS.
Inclusion criteria for this research comprised the need
for a diagnosis of mild-to-moderate OSAS, with the exclu-
sion of primary snorers (AHI < 5). Diagnosis was based on
overnight polysomnography, considered the gold standard
for OSAS diagnosis [26]. The diagnosis of lack of nasal ob-
struction was done using magnetic resonance imaging.
The following patients were excluded from the study:
(a) those who did not have at least eight teeth per arch
as they were unable to adequately retain the dental de-
vices, (b) those with severe periodontal problems since
the force delivered by the device to the teeth might
cause tooth loss, and (c) those with a history of tem-
poromandibular disorders due to the fact that the me-
chanics deployed by the mandibular advancement device
generates tension in the joint that might aggravate this
disorder. In this way, patients who were selected had
mild to moderate OSAS, without the presence of ad-
vanced periodontal disease or TMJ disorders, and with
more than eight teeth per arch.
The sample consisted of 19 individuals, 8 females and
11 males. The patients' mean age was 48.6 years (SD = 9.6,
min = 32.9, max = 64.6), and the mean body mass index
of the sample was 29.7. Eight of these individuals
presented with mild OSAS, ten with moderate OSAS, and
only 1 patient had a diagnosis of severe OSAS, but was in-
cluded in the study as he refused to use CPAP and had an
AHI value (31.1) very close to the cut-off value between
moderate and severe OSAS [1].
Appliance
A twin block (TB) experimental mandibular advance-
ment device was modified for use in this situation. It
consisted of two parts, one for the upper arch and one
for the lower. It was fabricated from self-curing acrylic
resin with occlusal coverage on all teeth so as to reduce
changes in tooth positioning that might arise from itsof the appliance in place.
Figure 2 Occlusal view of placebo device in place.
Table 2 AHI at baseline and after using twin block and
percentage reduction of OSAS
Patient AHI Reduction (%)
Baseline After use
1 17.6 8.6 51.3
2 10.2 1.8 82.3
3 15.1 26.1 −76.2
4 20.6 5.3 74.6
5 10.1 19.0 −89.3
6 23.4 17.4 25.6
7 12.7 2.0 84.3
8 13.1 7.9 39.9
9 31.1 4.0 87.1
10 7.9 7.0 11.5
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slopes with approximately 45° inclination which, when
joined, caused the mandible to advance by 75% of each
patient's maximum mandibular advancement capacity.
These slopes produced an interincisal opening of 8 mm
on average. To enhance retention of these devices, four
Adams clasps were placed bilaterally on the upper arch
(two on the canines and two on the first molars). These
clasps could be displaced in the absence of said teeth.
Two Adams clasps were placed bilaterally on the first
premolars of the lower arch with extensions toward the
canines with welded hooks. These clasps, like the ones
on the upper arch, could be displaced if these teeth were
missing. To ensure that the mandible would remain in
an advanced position during sleep, elastics were placed
connecting the Adams clasps on the upper canines with
the extension hook on the lower clasp. The elastic was
medium force, size 3/16 inch (Figure 1A,B).
The device used as placebo was an acrylic upper plate
covering the palate, with a labial arch made of 0.9-mm
wire contouring all the teeth and extending past the dis-
tal side of the last tooth, where it was fastened to the
acrylic plate, in what is known as wraparound device
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This was a prospective longitudinal crossover study with
an average 10.5-month follow-up, controlled through the
use of a placebo device. The sample was randomized, with
the order of use of devices drawn by lot, and the study was
double blind since neither the patients nor the doctors
who performed polysomnography for assessment of results
were aware of the placebo device. The polysomnographies
took place in two particular clinics in Rio de Janeiro,
Brazil. Both used the same device (Alice model, Philips
Respironics, Bothell, Washington, USA).
All patients who participated in the project used both
types of devices (experimental and control). Patients
were instructed to wear the devices only during sleep,
regardless of the time of day. The order of use was ran-
domly chosen by draw. The placebo device was worn for
a mean of 3.8 months (SD = 0.8); after which, the pa-
tients were subjected to follow-up polysomnography. TB
was used for a mean of 6.5 months (SD = 2.0), and over-
night polysomnography was performed after this period
to assess the results. Before placing the second device,
patients spent a week wearing nothing in order to avoid
any interference with the results.11 23.3 11.6 50.2
12 16.9 16.5 2.3
13 18.9 4.0 78.7
14 22.7 16.4 28.0
15 7.2 17.0 −135.7
16 5.1 6.1 −19.6
17 21.0 3.5 83.6
18 25.0 9.0 64.0
19 7.7 37.9 −394.5
Mean 16.3 11.7 2.5
SD 7.2 9.4 115.6
Table 3 AHI at baseline and after using wraparound
(placebo) and percentage reduction of OSAS
Patient AHI Reduction (%)
Baseline After use
1 17.6 20.4 −15.4
2 10.2 4.0 60.6
3 15.1 7.5 50.3
4 20.6 32.4 −56.9
5 10.1 18.0 −79.3
6 23.4 42.3 −81.3
7 12.7 32.5 −155.7
8 13.1 2.3 82.8
9 31.1 19.4 37.6
10 7.9 13.1 −65.3
11 23.3 0.9 96.0
12 16.9 25.6 −51.7
13 18.9 11.3 40.2
14 22.7 39.0 −71.8
15 7.2 1.4 81.0
16 5.1 9.6 −88.2
17 21.0 14.2 33.8
18 25.0 51.0 −104.0
19 7.7 27.8 −262.5
Mean 16.3 19.6 −28.9
SD 7.2 14.8 93.5
Teixeira et al. Progress in Orthodontics 2013, 14:10 Page 4 of 9
http://www.progressinorthodontics.com/content/14/1/10This research was submitted to the Ethics Committee
of Pedro Ernesto University Hospital and received ap-
proval number 1366-CEP/HUPE on December 19, 2005,
as it was found to conform to all ethical standards for re-
search in humans, according to resolution No. 196 issued
on October 10, 1996 by the National Health Council. All
patients signed a free and informed form of consent to








Apnea hypopnea Index-sequence TB- 
Wrap
Figure 3 Demonstration of AHI changes in group 1. Time 1,
baseline; time 2, with twin block; and time 3, with wraparound.Tests
The changes produced in OSAS by each appliance were
evaluated by comparing the data obtained in the initial
polysomnography test and the follow-up polysomnography
tests conducted with the use of each appliance at the end of
each given period. The following variables were assessed:
AHI, AI, mean oxyhemoglobin saturation, percentage of
REM sleep, and sleep efficiency.
Statistical analysis
Paired data were evaluated by the Wilcoxon test. The
Mann–Whitney test was used for evaluating unpaired
data. A 5% significance level was set for all tests (p < 0.05).
Results
Since this was a crossover study, with patients using both
types of appliances in random order, the Mann–Whitney
test was performed to check whether the results of each
appliance could be analyzed together, regardless of the
order in which the appliances were used. The test was
conducted at a significance level of 5%.
Comparisons between differences in AHI, AI, mean
percentage of O2 saturation, percentage of sleep effi-
ciency, and percentage of REM sleep were performed.
Table 1 shows the p value for each comparison. These
analyses led to the conclusion that statistically, the order
in which the appliances were placed had no influence on
index values, and therefore the two groups could be
evaluated together (n = 19).
The first evaluation was carried out using AHI as it is
the most widely used index to assess OSAS treatment ef-
ficacy. Patient improvement could only be determined
by a reduction in AHI greater than or equal to 50%. In
addition, to verify normalization, the final AHI should
be lower than 5. Tables 2 and 3 (for TB and WRAP, re-
spectively) were constructed based on these criteria.
The use of TB produced a reduction in AHI from








Apnea hypopnea Index-sequence Wrap- 
TB
Figure 4 Demonstration of AHI changes in group 2. Time 1,
baseline; time 2, with wraparound; time 3, with twin block.
Table 4 AI at baseline and after using twin block and
percentage reduction of OSAS
Patient AI Reduction (%)
Baseline After use
1 6.4 0.3 95.2
2 2.3 0.9 60.9
3 2.1 8.9 −322.4
4 4.9 0.8 84.7
5 1.6 10.4 −560.5
6 16.3 8.6 47.5
7 6.3 0.5 92.0
8 2.1 1.1 50.5
9 9.3 0.3 96.8
10 1.2 1.3 −11.8
11 3.1 2.7 12.3
12 4.1 12.1 −195.9
13 13.9 0.6 95.8
14 8.1 8.7 −6.8
15 2.0 11.3 −454.7
16 1.9 2.9 −53.9
17 3.7 0.1 96.5
18 15.2 0.7 95.6
19 3.3 0.6 82.3
Mean 5.7 3.8 −36.6
SD 4.8 4.4 199.7
Table 5 AI at baseline and after using wraparound
(placebo) and percentage reduction of OSAS
Patient AI Reduction (%)
Baseline After use
1 6.4 6.0 6.4
2 2.3 0.4 84.1
3 2.1 0.4 82.9
4 4.9 11.6 −137.1
5 1.6 6.3 −301.9
6 16.3 22.6 −38.4
7 6.3 23.2 −269.9
8 2.1 0.5 75.7
9 9.3 0.8 91.3
10 1.2 2.6 −119.3
11 3.1 0 100.0
12 4.1 11.2 −172.4
13 13.9 0.6 95.9
14 8.1 13.7 −68.5
15 2.0 0.7 66.0
16 1.9 2.4 −25.7
17 3.7 0.6 84.3
18 15.2 26.0 −71.0
19 3.3 13.0 −296.0
Mean 5.7 7.5 −42.8









Apnea Index-sequence TB-Wrap 
Figure 5 Demonstration of AI changes in group 1. Time 1,
baseline; time 2, with twin block; time 3, with wraparound.
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was no significant difference (p > 0.05) between the
group's initial and final means. The use of WRAP
yielded an increase in AHI from 16.3 (SD = 7.2) to 19.6
(SD = 14.8). There was also no statistically significant
difference (p > 0.05) between the means at the two
times (T1 and T2). A comparison was made between
the reductions in AHI produced by TB and WRAP
using the Mann–Whitney test at 5%, which revealed
no statistically significant difference between the two
(p = 0.2). Variations in AHI for each patient are shown
in Figures 3 and 4.
Changes in AI were evaluated in the same manner
as changes in AHI. Considering these criteria, Tables 4
and 5 were constructed for TB and WRAP, respectively.
The use of TB produced a reduction in AI from 5.7
(SD = 4.8) to 3.8 (SD = 4.4). Use of WRAP yielded an in-
crease in AI from 5.7 (SD = 4.8) to 7.5 (SD = 8.7). The
Wilcoxon paired test at 5% was employed for data ana-
lysis. There was no significant difference (p > 0.05) be-
tween the means at the two times (T1 and T2) for either
device. A comparison was made between the index reduc-
tions produced by each device using the Mann–Whitney
test at 5%, which revealed no statistically significantdifference between AI reductions (p = 0.4). Variations in
AI for each patient are shown in Figures 5 and 6.
The use of TB caused mean oxyhemoglobin saturation
to decrease from 94.3% (SD 2.5%) to 93.2% (SD 3.8%),
sleep efficiency to drop from 84.4% (SD 7.9%) to 78.6%
(SD 12.8%), and percentage of REM sleep to rise from
14.0% (SD 5.0%) to 16.0% (SD 5.0%). The use of WRAP








Apnea Index-sequence Wrap-TB  
Figure 6 Demonstration of AI changes in group 2. Time 1,
baseline; time 2, with wraparound; time 3, with twin block.
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ation. Sleep efficiency was reduced from 84.4% (SD 7.9%)
to 78.5% (SD 10.9%), and the percentage of REM sleep
mean values also remained unchanged, with differences
found only in standard deviation (Figures 7, 8, and 9).
The Wilcoxon paired test at 5% was employed for data
analysis of the means at T1 vs. T2. No significant differ-
ence (p > 0.05) was found between the means of the two
times for either device. A comparison between the results
achieved with the two devices was performed by means of
the Mann–Whitney test at 5%, which also showed no
statistically significant difference.
Discussion
The results of this study demonstrated clinically that the
twin block mandibular advancement device (TB) can be
an alternative treatment for OSAS, corroborating other
studies which found that oral appliances have indeed
emerged as an alternative treatment for this syndrome
[1,5,12-15,25,27]. Mandibular advancement devices are
more often indicated than CPAP given the former's greater
comfort, which theoretically would tend to increase
patient compliance and satisfaction leading to greater ad-






1 2 3 4 5 6 7 8 9 10 11 1
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Figure 7 Measurements of mean oxyhemoglobin saturation at baselicosts. All these factors hinder the use of CPAP, despite its
proven greater effectiveness.
The use of a modified TB was based on issues such as
cost, ease of fabrication, and greater mandibular mo-
tion. The cost, as reported by Eckhart [22] and Lawton
et al. [28], should be taken into account because now-
adays, OSAS is considered a public health problem
[29,30]; before, it is prescribed and applied to a large
portion of the population, it should become affordable.
For this reason, it is important that TB be easy to manu-
facture so it can be easily produced by a large number
of laboratories, requiring no training or very specific
materials, which could lead to increased costs and ac-
cess difficulties. Mandibular freedom of motion is yet
another factor that makes TB rather appropriate for use
in these situations. Mandibular freedom [12,31,32] fos-
ters patient comfort, both because patients do not feel
that their mouth is stuck and because it offers a certain
degree of joint comfort, since protrusion force in itself
tends to cause discomfort. Use time evaluated in the
study was approximately 6.5 months since the goal was
to evaluate long-term results and not just immediate re-
sults. This type of evaluation was considered more ap-
propriate because short-term evaluation [4,18,19,28,33-38]
might produce short-lived results, whereas this therapy
should last a whole life time. Two main factors are likely
to yield different assessments, depending on how long the
appliance is used: Airway enlargement caused by muscle
stretching and a reduction in upper airway edema [14,15].
WRAP was chosen as placebo as it does not cause any
changes in mandibular or tongue posture that might inter-
fere with the dynamic upper airway architecture and
might, therefore, fail to act as a true placebo. Such was the
case of the appliance used for this purpose by Blanco et al.
[33], Cooke and Battagel [34], Hans et al. [35], and
Johnston et al. [36] which, be it due to its size or even be-
cause it induced changes in mandibular position by virtue
of the opening it produced, can have a real impact on the
natural positioning of the structures. This might raise









Figure 8 Measurements of sleep efficiency at baseline, after twin block and after wraparound.
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time frame for placebo evaluation was set for after TB use.
Assuming that TB could have reduced the airway edema,
a minimum time period would be required to allow the
original conditions to be restored. Average TB use time
for assessment was approximately 4 months.
This study was undoubtedly limited by a small sample
size, which proved unable to demonstrate results statisti-
cally. All previous investigations that conducted this type of
assessment had equally limited samples [16,20,28,34,36,37].
Any research conducted with small samples, although pre-
dominant in this type of study, will only reveal clinical
trends without showing statistically significant differences.
This is mainly due to variations in individual responses,
which in small samples tend to confuse investigators. A sys-
tematic review of the Cochrane Library [39] found only six
studies that used placebos with appropriate methodology,
all with small sample sizes ranging from 15 to 28 subjects
[19,33-36,40] and likewise were only able to show clinical
trends. The findings of this study are therefore relevant
despite the lack of statistical significance. In seeking to con-
tribute to research aimed at validating this sort of therapy,
this was a prospective, longitudinal, randomized and
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% REM Sleep
Figure 9 Measurements of REM sleep at baseline, after twin block ansignificance level with 100% probability was set for statis-
tical analysis. To assess patient improvement, the most
stringent evaluation criteria ever employed in previous
studies was adopted. Patient condition was only considered
better if it showed a reduction of at least 50% of the initial
index and considered normal if the index was lower than
five, which was also considered in the studies by Almeida
et al. [16], Blanco et al. [33], Chan et al. [14], Clark et al. [3],
and Mehta et al. [19].
Based on this assessment, 47% of patients using TB
showed improvement in their condition and 26% had a
normal AHI, the most widely used index for treatment
evaluation. The index mean fell from 16.3 to 11.7. More-
over, 26% of patients using WRAP improved, and 21%
had their OSAS condition normalized, with AHI < 5.
The index mean, however, rose from 16.3 to 19.6.
The improvement rate achieved through TB use is
within the limits reported in the literature [41] and
could have been even better if less stringent standards
had been applied. For several researchers [7,17,20,25], an
AHI below 10 should be considered as good response,
although for Liu et al., [41], a reduction of 25% charac-
terizes a partial response. According to Lee et al. [15],
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below 20 can be deemed satisfactory. If an index reduc-
tion, be it of any magnitude, can be considered an im-
provement, this sample would have an index of 73.7%.
Although neither index has shown statistical signifi-
cance, a joint analysis of the indices suggests that TB may
be a clinical alternative for OSAS treatment. Nevertheless,
further investigation is clearly warranted. Other similarly
well-controlled studies should be conducted but with lar-
ger samples. Studies with small samples are prevalent in
this area due to difficulties in obtaining and controlling
the sample [20,28,34,36,39]. Only larger samples would
detect specific differences in evaluation methods, and in
the non-homogeneity of the sample, factors which are ex-
tremely difficult to control in an OSAS sample.
Above and beyond the authors' belief that this can be
an effective treatment, this study shows that variations
in individual response are substantial [12,19,20,28] and
that it is not possible to establish any specific treatment
without a strict control of individual responses, as has
been emphasized by the American Association of Sleep
Medicine [43]. This control can only be accomplished by
polysomnography, despite shortcomings inherent in this
test [13]. Individual improvement reports are not accept-
able since subjective improvements not always match
objective improvements [19,35], and systemic changes
produced by OSA may continue to progress if the condi-
tion is not controlled, even if the patient is feeling better.
Conclusions
The AHI and AI showed a decline in the mean value with
mandibular advanced device use and showed increase with
placebo use. For the mean oxygen saturation, the mandibu-
lar advancement device produced a drop at the index while
the placebo kept. Both devices produced worsening in sleep
efficiency, and the mandibular advanced device was able to
improve the percentage of REM sleep while placebo not.
All indexes did not show statistically significant difference
and showed quite a difference between patients. It can be
concluded that treatment with mandibular advancement
oral appliances can be an effective alternative but requires
strict monitoring due to differences in individual responses
to this therapy.
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